Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-012727
Filing Date
2020-11-05
Accepted
2020-11-05 08:15:04
Documents
52
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q albo-20200930x10q.htm   iXBRL 10-Q 1259219
2 EX-10.1 albo-20200930xex10d1.htm EX-10.1 266297
3 EX-10.2 albo-20200930xex10d2.htm EX-10.2 102244
4 EX-10.3 albo-20200930xex10d3.htm EX-10.3 77594
5 EX-31.1 albo-20200930xex31d1.htm EX-31.1 10377
6 EX-31.2 albo-20200930xex31d2.htm EX-31.2 10342
7 EX-32.1 albo-20200930xex32d1.htm EX-32.1 10547
  Complete submission text file 0001558370-20-012727.txt   4310888

Data Files

Seq Description Document Type Size
8 EX-101.SCH albo-20200930.xsd EX-101.SCH 29515
9 EX-101.CAL albo-20200930_cal.xml EX-101.CAL 31539
10 EX-101.DEF albo-20200930_def.xml EX-101.DEF 66426
11 EX-101.LAB albo-20200930_lab.xml EX-101.LAB 258036
12 EX-101.PRE albo-20200930_pre.xml EX-101.PRE 173094
13 EXTRACTED XBRL INSTANCE DOCUMENT albo-20200930x10q_htm.xml XML 459294
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33451 | Film No.: 201288808
SIC: 2834 Pharmaceutical Preparations